SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0000950170-24-034394
Filing Date
2024-03-21
Accepted
2024-03-20 21:53:19
Documents
190
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 40-F sndl-20231231.htm   iXBRL 40-F 358747
2 EX-97.1 sndl-ex97_1.htm EX-97.1 17037
3 2023 AIF sndl-ex99_1.htm EX-99.1 1079042
4 2023 FS sndl-ex99_2.htm   iXBRL EX-99.2 3319890
5 2023 MD&A sndl-ex99_3.htm EX-99.3 1265876
6 MARCUM CONSENT sndl-ex99_4.htm EX-99.4 6287
7 EX-99.5 CEO sndl-ex99_5.htm EX-99.5 11259
8 EX-99.6 CFO sndl-ex99_6.htm EX-99.6 11284
9 EX-99.7 CEO sndl-ex99_7.htm EX-99.7 4463
10 EX-99.8 CFO sndl-ex99_8.htm EX-99.8 8480
11 GRAPHIC img96328416_0.jpg GRAPHIC 4464
12 GRAPHIC img260723042_0.jpg GRAPHIC 4464
13 GRAPHIC img261646563_0.jpg GRAPHIC 4464
14 GRAPHIC img262570084_0.jpg GRAPHIC 4464
  Complete submission text file 0000950170-24-034394.txt   23474683

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sndl-20231231.xsd EX-101.SCH 3184144
194 EXTRACTED XBRL INSTANCE DOCUMENT sndl-20231231_htm.xml XML 5031530
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3
Business Address 919 11 AVENUE SW SUITE 300 CALGARY A0 T2R1P3 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 001-39005 | Film No.: 24769271
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)